Human PHACTR4/PPP1R124 ORF/cDNA clone-Lentivirus plasmid (NM_001350159)

Cat. No.: pGMLP003265
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human PHACTR4/PPP1R124 Lentiviral expression plasmid for PHACTR4 lentivirus packaging, PHACTR4 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.

pdf Datasheet
pdf MSDS
pdf Terms of Use
Target products collection

Go to PHACTR4/PPP1R124 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Purchase
Total Price: $1025.22
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMLP003265
Gene Name PHACTR4
Accession Number NM_001350159
Gene ID 65979
Species Human
Product Type Lentivirus plasmid (overexpression)
Insert Length 2133 bp
Gene Alias PPP1R124
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGGAAGATCCATTTGACTTCTCCAGAGAACCTTGGAACAAGGAAGCAGACCAGCCCACTACAGAGCCAGGCATGGTCCTGGACAGTGTGGAAGCAGGAGACACAACACCTCCTACCAAAAGGAAGAGCAAGTTCTCAGGCTTTGGCAAGATCTTCAAGCCCTGGAAATGGAGGAAAAAAAAAAGTAGTGATAAATTTAAAGAGACTTCAGAAGTTTTAGAACGGAAAATATCTATGCGAAAGCCAAGAGAAGAGCTGGTTAAAAGAGGGGTTCTGTTGGAAGACCCTGAGCAAGGTGGTGAGGATCCAGGAAAGCCAAGCGATGCCATGTTAAAGAATGGCCATACCACCCCCATAGGGAATGCCAGATCATCTAGTCCAGTCCAAGTAGAGGAAGAGCCAGTAAGATTAGCAAGTCTTAGGAAAGCTATTCCAGAAGAGGACCTAAAGAAACGACTAGGCTCAACTGGAAGCCAGCCTAATTCTGAAGCAGAGTCTGTTCCTGAGAATGTACCCAAACCACCTTTACTTCCTCCCAAAAGACCCTTGTCCTCTTCTCATGAAGCAAGTGAAGGGCAAGCAAAGGATGCCACTTCCTCTGGCGGCACGGCAAGGTTCATCATCTCCACCTCCATCACCACAGCACCCGCTGCCACCACTGCTGCCACAAGCCTTGCAAAGACTGTTAATCTCTCTGTCACCCCTTCCCCAGCACCCAGGACTCTGCCTGCTGCTCCTGCCAGCACTAACACTACTGCTACCCCAAGCCTCACTCATATGGTCCCTGCCAAGCAGCCCCCTATCCCTCCCCCTAAACCAGCTCACAGAAATAGCAACCCTGTCATTGCTGAACTGTCCCAAGCAATAAACAGTGGTACATTGTTATCAAAACCGTCCCCACCCTTACCACCTAAGAGAGGCATTCCATCAACCTCAGTACCCACCTTGGAGTCTGCTGCTGCCATCACCACAAAAACACCAAGTGATGAAAGAGAGAAGAGCACGTGTTCTATGGGCTCGGAACTACTACCAATGATCTCACCTCGCTCTCCGTCCCCCCCACTGCCTACTCATATACCTCCAGAGCCTCCACGCACCCCTCCATTCCCTGCTAAGACTTTTCAAGTTGTGCCAGAAATTGAGTTTCCACCATCCTTAGATCTACACCAGGAGATTCCCCAGCAGGAAGATCAGAAAAAGGAAGTCCCCAAGAGGATACTGGACCAGAACTTTGGGGAGCCCCATATACCCTCTAGGCTGCCTCCACTCCCACTGCATATTCGAATCCAGCAGGCCCTCACCAGCCCACTTCCCATGACTCCTATTCTGGAGGGTTCTCACAGAGCTCATTCGTTGCTTTTTGAAAACAGTGACAGCTTTTCTGAGGACAGCAGTACGCTGGGTCGGACCAGGTCTCTTCCCATCACTATTGAAATGCTAAAAGTTCCAGACGATGAAGAAGAAGAGGAGCAAACCTGTCCATCCACATTCAGTGAAGAAATGACACCTACCTCAGTCATTCCTAAATTACCACAGTGTCTACGGGAGGAAGAAGAGAAGGAGAGCGACTCTGATTCAGAAGGTCCCATTCAGTACCGAGATGAAGAAGATGAAGATGAAAGCTATCAGAGTGCTCTCGCCAACAAAGTGAAGAGGAAAGACACACTGGCAATGAAGTTGAACCACAGACCCAGTGAACCAGAGTTGAACCTGAATTCTTGGCCTTGTAAAAGCAAGGAGGAGTGGAATGAAATACGGCACCAGATTGGAAACACACTGATCCGGCGACTGAGTCAAAGACCAACACCAGAAGAACTAGAACAACGCAATATATTGCAACCTAAAAATGAAGCTGATCGTCAGGCAGAAAAACGAGAAATTAAACGTCGGCTCACTAGAAAGCTCAGTCAAAGGCCAACTGTCGCTGAACTCCTTGCCAGGAAGATTCTGAGGTTTAATGAATATGTAGAGGTAACAGATGCTCAAGATTATGACCGGCGAGCCGACAAACCTTGGACCAAACTGACCCCTGCTGACAAGGCTGCCATAAGAAAAGAATTAAATGAATTTAAAAGCTCCGAGATGGAGGTTCATGAAGAGAGCAAACATTTTACACGCTACCATCGTCCATGA
ORF Protein Sequence MEDPFDFSREPWNKEADQPTTEPGMVLDSVEAGDTTPPTKRKSKFSGFGKIFKPWKWRKKKSSDKFKETSEVLERKISMRKPREELVKRGVLLEDPEQGGEDPGKPSDAMLKNGHTTPIGNARSSSPVQVEEEPVRLASLRKAIPEEDLKKRLGSTGSQPNSEAESVPENVPKPPLLPPKRPLSSSHEASEGQAKDATSSGGTARFIISTSITTAPAATTAATSLAKTVNLSVTPSPAPRTLPAAPASTNTTATPSLTHMVPAKQPPIPPPKPAHRNSNPVIAELSQAINSGTLLSKPSPPLPPKRGIPSTSVPTLESAAAITTKTPSDEREKSTCSMGSELLPMISPRSPSPPLPTHIPPEPPRTPPFPAKTFQVVPEIEFPPSLDLHQEIPQQEDQKKEVPKRILDQNFGEPHIPSRLPPLPLHIRIQQALTSPLPMTPILEGSHRAHSLLFENSDSFSEDSSTLGRTRSLPITIEMLKVPDDEEEEEQTCPSTFSEEMTPTSVIPKLPQCLREEEEKESDSDSEGPIQYRDEEDEDESYQSALANKVKRKDTLAMKLNHRPSEPELNLNSWPCKSKEEWNEIRHQIGNTLIRRLSQRPTPEELEQRNILQPKNEADRQAEKREIKRRLTRKLSQRPTVAELLARKILRFNEYVEVTDAQDYDRRADKPWTKLTPADKAAIRKELNEFKSSEMEVHEESKHFTRYHRP

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-IP2652-Ab Anti-PHACTR4 monoclonal antibody
    Target Antigen GM-Tg-g-IP2652-Ag PHACTR4 protein
    ORF Viral Vector pGMLP003265 Human PHACTR4 Lentivirus plasmid
    ORF Viral Vector vGMLP003265 Human PHACTR4 Lentivirus particle


    Target information

    Target ID GM-IP2652
    Target Name PHACTR4
    Gene ID 65979, 100169, 716990, 682920, 487333, 514644, 100070745
    Gene Symbol and Synonyms 3110001B12Rik,C330013F19Rik,mKIAA4120,PHACTR4,PPP1R124
    Uniprot Accession Q8IZ21
    Uniprot Entry Name PHAR4_HUMAN
    Protein Sub-location Introcelluar Protein
    Category Not Available
    Disease Not Available
    Gene Ensembl ENSG00000204138
    Target Classification Not Available

    This gene encodes a member of the phosphatase and actin regulator (PHACTR) family. Other PHACTR family members have been shown to inhibit protein phosphatase 1 (PP1) activity, and the homolog of this gene in the mouse has been shown to interact with actin and PP1. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]



    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.